-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Veracyte, Raises Price Target to $50

Benzinga·01/05/2026 17:04:28
Listen to the news
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $45 to $50.